AIMS Cancer Outcomes Study

Launched by ADVANCED INTEGRATIVE MEDICAL SCIENCE INSTITUTE · Jul 31, 2020

Keywords

ClinConnect Summary

The AIMS Cancer Outcomes Study is a clinical trial that aims to understand how well different treatments work for patients with cancer. Specifically, it looks at how long patients with early-stage cancer live without their disease returning and how long patients with advanced cancer survive after receiving Advanced Integrative Oncology (AIO) treatment. The study will gather information from patients treated at the AIMS Institute to see how these treatments affect their health over time.

To participate in this study, you need to be a new patient having your first appointment or a current patient receiving treatment for cancer at AIMS. You must be at least 18 years old and able to understand the study details to give your consent. If you're under 18, a parent or guardian can consent for you. Unfortunately, patients without a cancer diagnosis or those who can't understand English well enough to participate cannot join. If you decide to participate, you can expect to provide some information about your health and treatment, helping researchers learn more about cancer care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. A new patient coming in for a first office call (FOC) or first consultation via telemedicine with a diagnosis of cancer, or
• • 2. An established patient with a diagnosis of cancer receiving treatment at the AIMS Institute;
• • 3. If over 18 years of age are able to understand study design adequately and provide signed informed consent (IC) to enrollment;
• • 4. If younger than 18 years of age informed assent from the child and informed consent from a parent or guardian who is able to understand the study design adequately and provide signed informed consent for the pediatric patient;
• • 5. A confirmed diagnosis of cancer based on medical oncology medical records.
• Exclusion Criteria:
• • 1. Patients not diagnosed with cancer;
• • 2. Telehealth patients;
• • 3. Cannot read or understand English well enough to read and sign the consent form and complete the questionnaires;
• • 4. Unwilling to participate in the AIMS Institute observational study.